These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15187645)

  • 1. The use of recombinant factor VIIa for severe intractable bleeding during spine surgery.
    Kaw LL; Coimbra R; Potenza BM; Garfin SR; Hoyt DB
    Spine (Phila Pa 1976); 2004 Jun; 29(12):1384-7; discussion 1388. PubMed ID: 15187645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
    Friederich PW; Henny CP; Messelink EJ; Geerdink MG; Keller T; Kurth KH; Büller HR; Levi M
    Lancet; 2003 Jan; 361(9353):201-5. PubMed ID: 12547542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
    Levi M; Peters M; Büller HR
    Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory monitoring of recombinant factor VIIA effects].
    Barkagan ZS; Mamaev AN; Tsyvkina LP; Mamaeva IV
    Klin Lab Diagn; 2007 May; (5):23-5. PubMed ID: 17665615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
    Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
    J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
    Ingerslev J
    Semin Thromb Hemost; 2000; 26(4):425-32. PubMed ID: 11092219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII.
    Tawfick WA; Tawfik S; Hynes N; Mahendran B; Sultan S
    Vascular; 2006; 14(1):32-7. PubMed ID: 16849021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures.
    Uhrig L; Blanot S; Baugnon T; Orliaguet G; Carli PA; Meyer PG
    Pediatr Crit Care Med; 2007 Nov; 8(6):576-9. PubMed ID: 18062085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.
    Vanek T; Straka Z; Hrabak J; Jares M; Brucek PJ; Votava J
    Jpn Heart J; 2004 Sep; 45(5):855-60. PubMed ID: 15557726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in the management of severe coagulopathy in trauma patients.
    Lynn M; Jeroukhimov I; Klein Y; Martinowitz U
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S241-7. PubMed ID: 12404093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.